Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Circulation Research Classics

Two Ways to Make Great Contributions

Donald D. Heistad
Download PDF
https://doi.org/10.1161/CIRCRESAHA.113.301831
Circulation Research. 2013;113:249-251
Originally published July 18, 2013
Donald D. Heistad
From the Departments of Internal Medicine and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA; Department of Medicine, University of Colorado, Denver, CO; and Department of Molecular, Cell, and Developmental Biology, University of Colorado, Boulder, CO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics

Jump to

  • Article
    • Introduction
    • Endothelial Function
    • Science and Society
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
Loading

Introduction

This commentary is about 2 investigators, Robert Furchgott and Stanton Glantz, who have written some of the most highly cited articles in Circulation Research. Furchgott and Glantz changed our scientific world and our society.

As I read the list of most highly cited articles in the 60 years of publication of Circulation Research, 2 stories came to mind. The first story is of a great discovery, and the second is of a great contribution to reduction of cardiovascular disease.

First is Robert Furchgott’s finding that endothelium is critical in normal vasomotor function of arteries. His finding was followed by a series of studies that demonstrated the importance of endothelial dysfunction in atherosclerosis, hypertension, and other diseases. Second is a story about Stanton Glantz, who made major contributions to our understanding of ventricular diastolic function, which foreshadowed our understanding of diastolic heart failure. However, for me, the truly inspiring story is how Glantz successfully challenged the tobacco industry, with enormous consequences for cardiovascular health.

Endothelial Function

Furchgott’s1 Brief Review, which is the article in Circulation Research with the third greatest number of citations, begins in his modest, understated manner: “A few years ago, we discovered that the relaxation by acetycholine of isolated preparations of arteries is strictly dependent on the presence of endothelial cells.” Several years before the Brief Review was published, Paul Vanhoutte had invited Furchgott to a small meeting to talk about his finding, which had been presented as an abstract. I talked with Furchgott, and thought that his finding was interesting, but not likely to be of great importance. I reasoned that there is not much acetylcholine in blood vessels, or in blood to which endothelium is exposed and, therefore, it was not likely that this vasorelaxing effect of acetylcholine in the aorta ex vivo was of much functional importance. The editors of Nature had more insight, and published his work.2

Francois Abboud, Michael Brody, Allyn Mark, and I were editors of Circulation Research, and we invited Furchgott to write the Brief Review. He described a series of studies that characterized effects of endothelium-derived relaxing factor (EDRF) in several physiological and disease states. He said “it is still too early to evaluate the physiological significance of relaxation of blood vessels that is endothelium-dependent and not mediated by prostaglandins.”

The importance of EDRF evolved in a series of studies in Circulation Research and other journals. Based on the finding that serotonin produces relaxation when endothelium is present, but contraction when endothelium is absent,3 we tested the hypothesis that atherosclerosis augments vasoconstrictor responses.4 We found that arterial vasoconstrictor responses to serotonin are greatly potentiated by atherosclerosis. Soon after, Freiman et al5 demonstrated that endothelium-dependent relaxation is impaired in atherosclerotic primates, and that endothelium-independent responses to nitroglycerin are normal. Verbeuren et al6 also reported that, when atherosclerosis develops, endothelium-dependent relaxation is impaired.

During the next few years, many studies demonstrated that atherosclerotic arteries generate excess superoxide, and that superoxide inactivates NO. Mügge et al7 found that chronic treatment with polyethylene-glycolated superoxide dismutase improves endothelium-dependent relaxation. It was known that endothelium generates high levels of superoxide in atherosclerotic arteries, but a surprise was that arterial media also is an important source of oxidative stress in atherosclerotic arteries.8

In his Brief Review, Furchgott1 said “the goal of chemically identifying EDRF that is released by Ach from endothelial cells will probably be difficult to achieve.” My view of Furchgott’s work is that the initial discovery of EDRF, which was the sine qua non of this area of research and his Nobel Prize, was serendipitous. For me, his brilliant work was to identify NO as EDRF. He first described a variety of characteristics and potential sources of EDRF. Then, in 1986, Furchgott and Louis Ignarro independently presented evidence that NO is EDRF. I admire their ability to move beyond mediators that seemed more likely, and to identify a gas (truly amazing at the time) as EDRF. When Ferid Murad demonstrated the role of cGMP in response to NO, the pathway was complete.

I have previously quoted9 the presentation speech at the award of the Nobel Prize in Physiology or Medicine, to Furchgott, Ignarro, and Murad in 1998: “the hunt for Furchgott’s endothelial factor came to an end during a scientific meeting…in the summer of 1986. At the meeting Furchgott concluded…that the factor was identical with NO. Ignarro supported this at the same meeting…[and] went one step further… The hunt was over. The riddle concerning the endothelial factor was finally solved…”

Science and Society

Stanton Glantz published a series of highly cited articles about ventricular mechanics.10–13 He pointed out “the diastolic pressure-volume curve’s ability to change can produce shifts in traditional ventricular function curves, even with no change in systolic performance.”10 Much later, we realized the importance of heart failure with normal systolic function, or diastolic heart failure.

Research is Glantz’ profession. He is also an activist, who is dedicated to studying and publicizing the health hazards of passive smoking. In 1994, presumably because of his activism, Glantz received a box of papers in the mail, with a return address “Mr. Butts.”14 I can only imagine the thrill when he opened the box to find a 4-foot pile of papers that implicated Brown and Williamson (B&W), the third-largest tobacco company, in a 30-year cover-up of effects of cigarettes smoking. Most of the information in this article about The Cigarette Papers is a summary of a Web source from http://PBS.org.14

What should Glantz have done with these papers that B&W said were stolen, and sued for their return? Glantz gave them to the University of California San Francisco Library, which made them available to the public, first scanned onto CDROM (high tech for the time) and then posted them on the Internet (even more high tech). I think this was a brilliant decision, although Glantz has a more modest explanation for the decision.14 When B&W declared that the articles were stolen, Glantz said “that resolved questions we had about the authenticity of the materials.”14

Key aspects of the B&W documents were that the tobacco industry had known for 30 years that cigarette smoking caused cancer and was addictive, and that they hid that information. The CEOs of the 7 largest tobacco companies had just sworn that they did not believe that cigarettes were addictive or caused cancer.14 Public access to the articles broke the dam that had slowed progress in limiting smoking.

There are many courageous heroes in this story, including Stanton Glantz, the University of California, and the University library, who presumably knew the legal challenges that they would receive from the tobacco industry. In addition, the Journal of the American Medical Association (JAMA) published 5 articles by Glantz about the B&W documents.15–19 Each of the articles was reviewed by 8 reviewers. The 5 articles went beyond health effects of smoking, and described ways that B&W managed research and publications. One of the articles indicated that B&W suppressed its own research, which indicated that smoking causes cancer, by sending the material to its legal department. B&W lawyers claimed that the material was protected by attorney-client privilege, and did not need to be disclosed.14

An editorial that accompanied the articles in JAMA said that tobacco companies have “managed to remain highly profitable from the sale of a substance long known by scientists and physicians to be lethal.”20 The editorial was unique because it was cowritten, and cosigned, by the editors and the board of trustees, president, and president-elect of the AMA. Release of the B&W documents and the subsequent scholarship had a profound effect on the debate over tobacco, and contributed to state and federal litigation against the tobacco companies, ultimate enactment of legislation granting the Food and Drug Administration authority over tobacco, and contributed to passage of the first global public health treaty, the World Health Organization Framework Convention on Tobacco Control.

The online collection at the UCSF Library (http:/legacy.library.ucsf.edu), which is now >83 million pages of documents, has formed the basis for >800 peer reviewed scientific articles and other publications about the tobacco industry (http:/legacy.library.ucsf.edu/tobacco/docsbiblio).

In the articles in JAMA, and in his book The Cigarette Papers,21 Glantz acknowledged grant support from the National Cancer Institute (NCI). The grant was in response to an NCI solicitation to “evaluate the effect of advocacy in the development of tobacco control policy.”14 In response to a public relations and lobbying campaign by the tobacco industry, the House Appropriations Committee attached a rider to the NCI appropriation defunding the last year of Glantz’ grant.22 A subcommittee report indicated that the grant did “not properly fall within the boundaries of the NCI portfolio.” To my knowledge, this was the first NCI grant to be singled out by Congress for defunding. The scientific community responded and, as a result, the rider was removed in the Senate and Glantz’ grant continued. I am pleased to see that recent studies by Glantz (eg23) were supported by the same grant from the NCI. It is disappointing, however, that the House Appropriations Committee is again looking into NIH funding of Glantz’ research.24

Finally, there is a relationship between the 2 short stories in this commentary. The year that JAMA published the articles related to the B&W documents, it was demonstrated that cigarette smoking is a risk factor for endothelial dysfunction (eg25). Since then, many articles have confirmed and extended the finding. Tan and Glantz23 have suggested that reduction in passive smoking may have contributed to the rapid decrease in acute myocardial infarction that followed implementation of smoke free laws.

Acknowledgments

I thank Stanton Glantz for confirming the accuracy of the section related to the B&W documents, and Francois Abboud, David Harrison, and Michael Welsh for their suggestions.

Disclosures

Original studies by the author are supported by the National Institutes of Health grants HL-62984 and NS 72628.

Footnotes

  • To mark the 60th birthday of Circulation Research (1953–2013), the editors have commissioned Circulation Research Classics, a series of commentaries highlighting seminal articles published in the journal during the past 6 decades that have importantly shaped cardiovascular research. Written by leading experts, Circulation Research Classics are intended to describe the impact of these articles on the field by putting them in a historical perspective. The concept of classic is inextricably linked to time—a classic is something that maintains its value regardless of its age. Thus, an important consideration in selecting the articles to be highlighted is that they have stood the test of time, which is the most reliable indicator of the value of scientific work. By looking back at the illustrious past of Circulation Research, we hope to promote a deeper appreciation of the contributions of this journal to the advancement of knowledge.

  • The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

  • © 2013 American Heart Association, Inc.

References

  1. 1.↵
    1. Furchgott RF
    . Role of endothelium in responses of vascular smooth muscle. Circ Res. 1983;53:557–573.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Furchgott RF,
    2. Zawadzki JV
    . The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Cohen RA,
    2. Shepherd JT,
    3. Vanhoutte PM
    . Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science. 1983;221:273–274.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Heistad DD,
    2. Armstrong ML,
    3. Marcus ML,
    4. Piegors DJ,
    5. Mark AL
    . Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984;54:711–718.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Freiman PC,
    2. Mitchell GG,
    3. Heistad DD,
    4. Armstrong ML,
    5. Harrison DG
    . Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin. Circ Res. 1986;58:783–789.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Verbeuren TJ,
    2. Coene MC,
    3. Jordaens FH,
    4. Van Hove CE,
    5. Zonnekeyn LL,
    6. Herman AG
    . Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits. Circ Res. 1986;59:496–504.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Mügge A,
    2. Elwell JH,
    3. Peterson TE,
    4. Hofmeyer TG,
    5. Heistad DD,
    6. Harrison DG
    . Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991;69:1293–1300.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Miller FJ Jr.,
    2. Gutterman DD,
    3. Rios CD,
    4. Heistad DD,
    5. Davidson BL
    . Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998;82:1298–1305.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Heistad DD
    . Endothelial function in the time of the giants. J Cardiovasc Pharmacol. 2008;52:385–392.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Glantz SA,
    2. Parmley WW
    . Factors which affect the diastolic pressure-volume curve. Circ Res. 1978;42:171–180.
    OpenUrlFREE Full Text
  11. 11.↵
    1. Glantz SA,
    2. Misbach GA,
    3. Moores WY,
    4. Mathey DG,
    5. Lekven J,
    6. Stowe DF,
    7. Parmley WW,
    8. Tyberg JV
    . The pericardium substantially affects the left ventricular diastolic pressure-volume relationship in the dog. Circ Res. 1978;42:433–441.
    OpenUrlFREE Full Text
  12. 12.↵
    1. Gilbert JC,
    2. Glantz SA
    . Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res. 1989;64:827–852.
    OpenUrlFREE Full Text
  13. 13.↵
    1. Raff GL,
    2. Glantz SA
    . Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart. Circ Res. 1981;48:813–824.
    OpenUrlFREE Full Text
  14. 14.↵
    1. Wiener J
    . The cigarette papers. In: Frontline: PBS Online. http://www.pbs.org/wgbh/pages/frontline/smoke/readings/wienerarticle.html.
  15. 15.↵
    1. Glantz SA,
    2. Barnes DE,
    3. Bero L,
    4. Hanauer P,
    5. Slade J
    . Looking through a keyhole at the tobacco industry. The Brown and Williamson documents. JAMA. 1995;274:219–224.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Slade J,
    2. Bero LA,
    3. Hanauer P,
    4. Barnes DE,
    5. Glantz SA
    . Nicotine and addiction. The Brown and Williamson documents. JAMA. 1995;274:225–233.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Hanauer P,
    2. Slade J,
    3. Barnes DE,
    4. Bero L,
    5. Glantz SA
    . Lawyer control of internal scientific research to protect against products liability lawsuits. The Brown and Williamson documents. JAMA. 1995;274:234–240.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Bero L,
    2. Barnes DE,
    3. Hanauer P,
    4. Slade J,
    5. Glantz SA
    . Lawyer control of the tobacco industry’s external research program. The Brown and Williamson documents. JAMA. 1995;274:241–47.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Barnes DE,
    2. Hanauer P,
    3. Slade J,
    4. Bero LA,
    5. Glantz SA
    . Environmental tobacco smoke. The Brown and Williamson documents. JAMA. 1995;274:248–253.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Todd JS,
    2. Rennie D,
    3. McAfee RE
    . The Brown and Williamson documents: where do we go from here? JAMA. 1995;274:256–258.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Glantz SA,
    2. Slade J,
    3. Bero LA,
    4. Hanauer P,
    5. Barnes DE
    . The Cigarette Papers. Berkeley, CA: University of California Press; 1996.
  22. 22.↵
    1. Landman A,
    2. Glantz SA
    . Tobacco industry efforts to undermine policy-relevant research. Am J Public Health. 2009;99:45–58.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Tan CE,
    2. Glantz SA
    . Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases. Circulation. 2012;126:2177–2183.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Goldberg P
    . House appropriation claims NCI, NLM grants funded political activity, seeks OIG probe. The Cancer Letter. 2013;39:1–10.
    OpenUrl
  25. 25.↵
    1. Zeiher AM,
    2. Schächinger V,
    3. Minners J
    . Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995;92:1094–1100.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
July 19, 2013, Volume 113, Issue 3
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Introduction
    • Endothelial Function
    • Science and Society
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Two Ways to Make Great Contributions
    Donald D. Heistad
    Circulation Research. 2013;113:249-251, originally published July 18, 2013
    https://doi.org/10.1161/CIRCRESAHA.113.301831

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Two Ways to Make Great Contributions
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Two Ways to Make Great Contributions
    Donald D. Heistad
    Circulation Research. 2013;113:249-251, originally published July 18, 2013
    https://doi.org/10.1161/CIRCRESAHA.113.301831
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Myocardial Biology
    • Endothelium/Vascular Type/Nitric Oxide

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured